These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 2534890)
1. Effect of streptozotocin-induced diabetes on the structure of heparan sulfate from rat kidneys. Kamada A J Osaka Dent Univ; 1989 Oct; 23(2):63-75. PubMed ID: 2534890 [TBL] [Abstract][Full Text] [Related]
2. Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats. Kumar GS; Shetty AK; Salimath PV J Ethnopharmacol; 2008 Jan; 115(2):276-83. PubMed ID: 18024034 [TBL] [Abstract][Full Text] [Related]
3. Aberrant heparan sulfate profile in the human diabetic kidney offers new clues for therapeutic glycomimetics. Wijnhoven TJ; Lensen JF; Rops AL; van der Vlag J; Kolset SO; Bangstad HJ; Pfeffer P; van den Hoven MJ; Berden JH; van den Heuvel LP; van Kuppevelt TH Am J Kidney Dis; 2006 Aug; 48(2):250-61. PubMed ID: 16860191 [TBL] [Abstract][Full Text] [Related]
4. Vessel wall heparan sulfate and transcapillary passage of albumin in experimental diabetes in the rat. van den Born J; van Kraats AA; Hill S; Bakker MA; Berden JH Nephrol Dial Transplant; 1997; 12 Suppl 2():27-31. PubMed ID: 9269696 [TBL] [Abstract][Full Text] [Related]
5. Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes. Templeton DM Lab Invest; 1989 Aug; 61(2):202-11. PubMed ID: 2755078 [TBL] [Abstract][Full Text] [Related]
6. [(35)S]sulfate incorporation into glomerular basement membrane glycosaminoglycans is decreased in experimental diabetes. Cohen MP; Surma ML J Lab Clin Med; 1981 Nov; 98(5):715-22. PubMed ID: 7028893 [TBL] [Abstract][Full Text] [Related]
7. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats. Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983 [TBL] [Abstract][Full Text] [Related]
8. Consequences of prolonged inhalation of ozone on F344/N rats: collaborative studies. Part III: Effects on complex carbohydrates of lung connective tissue. Radhakrishnamurthy B Res Rep Health Eff Inst; 1994 Sep; (65 Pt 3):3-14; discussion 15-23. PubMed ID: 7811421 [TBL] [Abstract][Full Text] [Related]
9. Rat heparan sulphates. A study of the antithrombin-binding properties of heparan sulphate chains from rat adipose tissue, brain, carcase, heart, intestine, kidneys, liver, lungs, skin and spleen. Horner AA Biochem J; 1990 Mar; 266(2):553-9. PubMed ID: 2138457 [TBL] [Abstract][Full Text] [Related]
10. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura. McAuliffe AV; Fisher EJ; McLennan SV; Yue DK; Turtle JR Diabet Med; 1996 Aug; 13(8):758-63. PubMed ID: 8862953 [TBL] [Abstract][Full Text] [Related]
11. Effect of galactose regimen on glomerular heparan sulfate synthesis and albumin excretion in diabetic rats. Jaya B; Hu L; Bauman JW; Fu SC; Reddi AS Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):143-52. PubMed ID: 8321919 [TBL] [Abstract][Full Text] [Related]
12. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin. Lewis EJ; Xu X Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486 [TBL] [Abstract][Full Text] [Related]
13. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy. Tomohiro T; Kumai T; Sato T; Takeba Y; Kobayashi S; Kimura K Life Sci; 2007 Mar; 80(15):1364-72. PubMed ID: 17331548 [TBL] [Abstract][Full Text] [Related]
14. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats. Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596 [TBL] [Abstract][Full Text] [Related]
15. Effect of aspirin on experimental diabetic nephropathy. Moel DI; Safirstein RL; McEvoy RC; Hsueh W J Lab Clin Med; 1987 Sep; 110(3):300-7. PubMed ID: 3475395 [TBL] [Abstract][Full Text] [Related]
16. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. McLennan SV; Kelly DJ; Cox AJ; Cao Z; Lyons JG; Yue DK; Gilbert RE Diabetologia; 2002 Feb; 45(2):268-75. PubMed ID: 11935159 [TBL] [Abstract][Full Text] [Related]
17. Protective effect of nicotinamide against nephropathy in diabetic rats. Wahlberg G; Carlson LA; Wasserman J; Ljungqvist A Diabetes Res; 1985 Nov; 2(6):307-12. PubMed ID: 2934204 [TBL] [Abstract][Full Text] [Related]
18. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin. Klein DJ; Dehnel PJ; Oegema TR; Brown DM Lab Invest; 1984 May; 50(5):543-51. PubMed ID: 6232422 [TBL] [Abstract][Full Text] [Related]
20. In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria. Wijnhoven TJ; Lensen JF; Wismans RG; Lamrani M; Monnens LA; Wevers RA; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH J Am Soc Nephrol; 2007 Mar; 18(3):823-32. PubMed ID: 17251387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]